Mycrodose Therapeutics Receives US DEA Schedule I License to Research Four (4) Psychedelic Compounds

San Diego, California (PRWEB) August 20, 2021 -- Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug

Related Keywords

State Of California ,California ,United States ,San Diego ,Patrick Eckstrom ,Frank Kochinke ,Research Advisory Board ,Us Food Drug Administration ,United States Drug Enforcement Agency ,Mycrodose Therapeutics An Advanced Drug Delivery Company ,Mycrodose Therapeutics ,Advanced Drug Delivery ,Chief Science ,California Attorney General ,Drug Administration ,Mycrodose Therapeutic ,Schedulei License ,Chad Conner ,Chief Executive ,Operating Officer ,Press Release ,